These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21344316)

  • 1. Genetic variability of pain perception and treatment--clinical pharmacological implications.
    Lötsch J
    Eur J Clin Pharmacol; 2011 Jun; 67(6):541-51. PubMed ID: 21344316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of new analgesics.
    Lötsch J; Geisslinger G
    Br J Pharmacol; 2011 Jun; 163(3):447-60. PubMed ID: 20942817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic modulation of the pharmacological treatment of pain.
    Lötsch J; Geisslinger G; Tegeder I
    Pharmacol Ther; 2009 Nov; 124(2):168-84. PubMed ID: 19615406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical appraisal of human genotyping for pain therapy.
    Lötsch J; Geisslinger G
    Trends Pharmacol Sci; 2010 Jul; 31(7):312-7. PubMed ID: 20483491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor and Molecular Targets for the Development of Novel Opioid and Non-Opioid Analgesic Therapies.
    Chen R; Coppes OJM; Urman RD
    Pain Physician; 2021 Mar; 24(2):153-163. PubMed ID: 33740349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic mutations that prevent pain: implications for future pain medication.
    Oertel B; Lötsch J
    Pharmacogenomics; 2008 Feb; 9(2):179-94. PubMed ID: 18370847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scientometrics of drug discovery efforts: pain-related molecular targets.
    Kissin I
    Drug Des Devel Ther; 2015; 9():3393-404. PubMed ID: 26170624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New molecules for the treatment of pain.
    Heinzmann S; McMahon SB
    Curr Opin Support Palliat Care; 2011 Jun; 5(2):111-5. PubMed ID: 21455071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics and Personalized Medicine in Pain Management.
    Webster LR; Belfer I
    Clin Lab Med; 2016 Sep; 36(3):493-506. PubMed ID: 27514464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional genomics of pain in analgesic drug development and therapy.
    Lötsch J; Doehring A; Mogil JS; Arndt T; Geisslinger G; Ultsch A
    Pharmacol Ther; 2013 Jul; 139(1):60-70. PubMed ID: 23567662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
    Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH
    J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics in pain management: the clinical need.
    Webster LR
    Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic Effects Mediated by Muscarinic Receptors: Mechanisms and Pharmacological Approaches.
    De Angelis F; Tata AM
    Cent Nerv Syst Agents Med Chem; 2016; 16(3):218-226. PubMed ID: 26931765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological pathways and genetic variables involved in pain.
    Shi Q; Cleeland CS; Klepstad P; Miaskowski C; Pedersen NL;
    Qual Life Res; 2010 Dec; 19(10):1407-17. PubMed ID: 20842532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpreting patient treatment response in analgesic clinical trials: implications for genotyping, phenotyping, and personalized pain treatment.
    Dworkin RH; McDermott MP; Farrar JT; O'Connor AB; Senn S
    Pain; 2014 Mar; 155(3):457-460. PubMed ID: 24071599
    [No Abstract]   [Full Text] [Related]  

  • 16. Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity.
    Capsoni S; Covaceuszach S; Marinelli S; Ceci M; Bernardo A; Minghetti L; Ugolini G; Pavone F; Cattaneo A
    PLoS One; 2011 Feb; 6(2):e17321. PubMed ID: 21387003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic mediation of individual differences in sensitivity to pain and its inhibition.
    Mogil JS
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7744-51. PubMed ID: 10393892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient receptor potential channels - emerging novel drug targets for the treatment of pain.
    Sałat K; Moniczewski A; Librowski T
    Curr Med Chem; 2013; 20(11):1409-36. PubMed ID: 23409716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacogenetics of analgesia: toward a genetically-based approach to pain management.
    Flores CM; Mogil JS
    Pharmacogenomics; 2001 Aug; 2(3):177-94. PubMed ID: 11535108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LQT syndromes--current status of molecular mechanisms.
    Schulze-Bahr E; Wedekind H; Haverkamp W; Borggrefe M; Assmann G; Breithardt G; Funke H
    Z Kardiol; 1999 Apr; 88(4):245-54. PubMed ID: 10408028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.